RAC reviews serious adverse event associated with AAV therapy trial
Williams, David A.
Molecular Therapy 2007 December; 15(12): 2053-2054
Showing items related by title, author, creator and subject.
NIH recombinant DNA Advisory Committee continues to ponder adverse event associated with AAV gene therapy trial Williams, David A. (2008-03)
A serious adverse event after successful gene therapy for X- linked severe combined immunodeficiency Hacein-Bey-Abina, Salima; von Kalle, Christof; Schmidt, Manfred; Le Deist, Francoise; Wulffraat, Nicolas; McIntyre, Elisabeth; Radford, Isabelle; Villeval, Jean-Luc; Fraser, Christopher C.; Cavazzana-Calvo, Marina; Fischer, Alain (2003-01-16)
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy European Society of Gene Therapy [ESGT] (2003-01)